Skip to main content
Erschienen in: Acta Diabetologica 6/2016

05.05.2016 | Original Article

Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus

verfasst von: Hui Ning, Hong Tao, Zhanping Weng, Xingbo Zhao

Erschienen in: Acta Diabetologica | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Aims

Fatty acid-binding protein 4 (FABP4) is mainly expressed in adipocytes and macrophages and is demonstrated to be elevated in diabetes patients. The aim of this study was to evaluate the possible role of FABP4 in the diagnosis of GDM and to investigate the relationship between FABP4 and overweight, insulin resistance and inflammatory marker TNF-α.

Methods

A total of 46 women with GDM and 55 age-matched pregnant women without GDM (non-GDM) were eligible for the study. Demographic and biochemical parameters and fasting venous blood samples of two groups were collected from all cases. Serum concentrations of FABP4 were determined using enzyme-linked immunosorbent assay (ELISA). The predictive value of Serum FABP4 level was evaluated using receiver operating characteristic curve (ROC curve) analysis.

Results

We found that the serum FABP4 levels were significantly higher in GDM compared to the non-GDM group. The area under the ROC curve assay yielded a satisfactory result of 0.94 (95 % confidence interval 0.90–0.98; p < 0.001). The best compromise between 86.96 % specificity and 89.09 % sensitivity was obtained with a cutoff value of 1.96 ng/mL for GDM diagnosis. Moreover, a significant positive correlation was observed between FABP4 and overweight, insulin resistance and TNF-α in pregnant women with GDM.

Conclusions

These results suggest that serum FABP4 may potentially serve as a novel biomarker for the prediction of GDM.
Literatur
2.
Zurück zum Zitat Ben-Haroush A, Yogev Y, Hod M (2004) Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med 21:103–113CrossRefPubMed Ben-Haroush A, Yogev Y, Hod M (2004) Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med 21:103–113CrossRefPubMed
3.
Zurück zum Zitat El-Chaar D, Finkelstein SA, Tu X et al (2013) The impact of increasing obesity class on obstetrical outcomes. J Obstet Gynaecol Can 35:224–233CrossRefPubMed El-Chaar D, Finkelstein SA, Tu X et al (2013) The impact of increasing obesity class on obstetrical outcomes. J Obstet Gynaecol Can 35:224–233CrossRefPubMed
5.
9.
Zurück zum Zitat Hunt CR, Ro JH, Dobson DE, Min HY, Spiegelman BM (1986) Adipocyte P2 gene: developmental expression and homology of 5′-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci USA 83:3786–3790CrossRefPubMed Hunt CR, Ro JH, Dobson DE, Min HY, Spiegelman BM (1986) Adipocyte P2 gene: developmental expression and homology of 5′-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci USA 83:3786–3790CrossRefPubMed
10.
Zurück zum Zitat Spiegelman BM, Frank M, Green H (1983) Molecular cloning of mRNA from 3T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. J Biol Chem 258:10083–10089PubMed Spiegelman BM, Frank M, Green H (1983) Molecular cloning of mRNA from 3T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. J Biol Chem 258:10083–10089PubMed
11.
Zurück zum Zitat Baxa CA, Sha RS, Buelt MK et al (1989) Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA. Biochemistry 28:8683–8690CrossRefPubMed Baxa CA, Sha RS, Buelt MK et al (1989) Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA. Biochemistry 28:8683–8690CrossRefPubMed
12.
Zurück zum Zitat Amri EZ, Bertrand B, Ailhaud G, Grimaldi P (1991) Regulation of adipose cell differentiation I. Fatty acids are inducers of the aP2 gene expression. J Lipid Res 32:1449–1456PubMed Amri EZ, Bertrand B, Ailhaud G, Grimaldi P (1991) Regulation of adipose cell differentiation I. Fatty acids are inducers of the aP2 gene expression. J Lipid Res 32:1449–1456PubMed
13.
Zurück zum Zitat Melki SA, Abumrad NA (1993) Expression of the adipocyte fatty acid-binding protein in streptozotocin-diabetes: effects of insulin deficiency and supplementation. J Lipid Res 34:1527–1534PubMed Melki SA, Abumrad NA (1993) Expression of the adipocyte fatty acid-binding protein in streptozotocin-diabetes: effects of insulin deficiency and supplementation. J Lipid Res 34:1527–1534PubMed
16.
Zurück zum Zitat Tso AW, Xu A, Sham PC et al (2007) Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 30:2667–2672. doi:10.2337/dc07-0413 CrossRefPubMed Tso AW, Xu A, Sham PC et al (2007) Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 30:2667–2672. doi:10.​2337/​dc07-0413 CrossRefPubMed
20.
24.
Zurück zum Zitat International Association of D, Pregnancy Study Groups Consensus P, Metzger BE et al (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682. doi:10.2337/dc09-1848 CrossRef International Association of D, Pregnancy Study Groups Consensus P, Metzger BE et al (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682. doi:10.​2337/​dc09-1848 CrossRef
25.
Zurück zum Zitat Hartling L, Dryden DM, Guthrie A et al. (2012) Screening and diagnosing gestational diabetes mellitus. Evid Rep Technol Assess (Full Rep) 12:1–327 Hartling L, Dryden DM, Guthrie A et al. (2012) Screening and diagnosing gestational diabetes mellitus. Evid Rep Technol Assess (Full Rep) 12:1–327
28.
Zurück zum Zitat Zhao C, Wang F, Wang P, Ding H, Huang X, Shi Z (2015) Early second-trimester plasma protein profiling using multiplexed isobaric tandem mass tag (TMT) labeling predicts gestational diabetes mellitus. Acta Diabetol 52:1103–1112. doi:10.1007/s00592-015-0796-y CrossRefPubMed Zhao C, Wang F, Wang P, Ding H, Huang X, Shi Z (2015) Early second-trimester plasma protein profiling using multiplexed isobaric tandem mass tag (TMT) labeling predicts gestational diabetes mellitus. Acta Diabetol 52:1103–1112. doi:10.​1007/​s00592-015-0796-y CrossRefPubMed
29.
30.
33.
Zurück zum Zitat Rhee EJ, Lee WY, Park CY et al (2009) The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. Eur J Endocrinol 160:165–172. doi:10.1530/EJE-08-0665 CrossRefPubMed Rhee EJ, Lee WY, Park CY et al (2009) The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. Eur J Endocrinol 160:165–172. doi:10.​1530/​EJE-08-0665 CrossRefPubMed
34.
Zurück zum Zitat Biron-Shental T, Schaiff WT, Ratajczak CK, Bildirici I, Nelson DM, Sadovsky Y (2007) Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. Am J Obstet Gynecol 197(516):e511–e516. doi:10.1016/j.ajog.2007.03.066 CrossRef Biron-Shental T, Schaiff WT, Ratajczak CK, Bildirici I, Nelson DM, Sadovsky Y (2007) Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. Am J Obstet Gynecol 197(516):e511–e516. doi:10.​1016/​j.​ajog.​2007.​03.​066 CrossRef
36.
Zurück zum Zitat Nourani MR, Owada Y, Kitanaka N et al (2005) Occurrence of immunoreactivity for adipocyte-type fatty acid binding protein in degenerating granulosa cells in atretic antral follicles of mouse ovary. J Mol Histol 36:491–497. doi:10.1007/s10735-006-9024-y CrossRefPubMed Nourani MR, Owada Y, Kitanaka N et al (2005) Occurrence of immunoreactivity for adipocyte-type fatty acid binding protein in degenerating granulosa cells in atretic antral follicles of mouse ovary. J Mol Histol 36:491–497. doi:10.​1007/​s10735-006-9024-y CrossRefPubMed
40.
Zurück zum Zitat Di Cianni G, Lencioni C, Volpe L et al (2007) C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 23:135–140. doi:10.1002/dmrr.661 CrossRefPubMed Di Cianni G, Lencioni C, Volpe L et al (2007) C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 23:135–140. doi:10.​1002/​dmrr.​661 CrossRefPubMed
41.
Zurück zum Zitat Heitritter SM, Solomon CG, Mitchell GF, Skali-Ounis N, Seely EW (2005) Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 90:3983–3988. doi:10.1210/jc.2004-2494 CrossRefPubMed Heitritter SM, Solomon CG, Mitchell GF, Skali-Ounis N, Seely EW (2005) Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 90:3983–3988. doi:10.​1210/​jc.​2004-2494 CrossRefPubMed
42.
Zurück zum Zitat Winzer C, Wagner O, Festa A et al (2004) Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27:1721–1727CrossRefPubMed Winzer C, Wagner O, Festa A et al (2004) Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27:1721–1727CrossRefPubMed
44.
Zurück zum Zitat Baeten JM, Bukusi EA, Lambe M (2001) Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health 91:436–440CrossRefPubMedPubMedCentral Baeten JM, Bukusi EA, Lambe M (2001) Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health 91:436–440CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Kim SY, Sappenfield W, Sharma AJ et al (2013) Racial/ethnic differences in the prevalence of gestational diabetes mellitus and maternal overweight and obesity, by nativity, Florida, 2004-2007. Obesity (Silver Spring) 21:E33–E40. doi:10.1002/oby.20025 CrossRef Kim SY, Sappenfield W, Sharma AJ et al (2013) Racial/ethnic differences in the prevalence of gestational diabetes mellitus and maternal overweight and obesity, by nativity, Florida, 2004-2007. Obesity (Silver Spring) 21:E33–E40. doi:10.​1002/​oby.​20025 CrossRef
47.
Zurück zum Zitat Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862–1868CrossRefPubMed Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862–1868CrossRefPubMed
49.
51.
Zurück zum Zitat Jansson N, Rosario FJ, Gaccioli F et al (2013) Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. J Clin Endocrinol Metab 98:105–113. doi:10.1210/jc.2012-2667 CrossRefPubMed Jansson N, Rosario FJ, Gaccioli F et al (2013) Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. J Clin Endocrinol Metab 98:105–113. doi:10.​1210/​jc.​2012-2667 CrossRefPubMed
52.
Zurück zum Zitat Jansson T, Ekstrand Y, Bjorn C, Wennergren M, Powell TL (2002) Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes 51:2214–2219CrossRefPubMed Jansson T, Ekstrand Y, Bjorn C, Wennergren M, Powell TL (2002) Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes 51:2214–2219CrossRefPubMed
53.
54.
59.
Zurück zum Zitat Ahima RS, Flier JS (2000) Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11:327–332CrossRefPubMed Ahima RS, Flier JS (2000) Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11:327–332CrossRefPubMed
Metadaten
Titel
Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus
verfasst von
Hui Ning
Hong Tao
Zhanping Weng
Xingbo Zhao
Publikationsdatum
05.05.2016
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 6/2016
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-016-0867-8

Weitere Artikel der Ausgabe 6/2016

Acta Diabetologica 6/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.